Table 1 The strains and probiotic characteristics of reported L. reuteri
From: Study and use of the probiotic Lactobacillus reuteri in pigs: a review
Strain | Source | Characteristics | Reference |
|---|---|---|---|
L. reuteri I5007 | piglets | strong adhesion, competitiveness against pathogens; improved pig performance, immune function and antioxidant status; alleviated the weaning stress syndrome; modulated gut microflora | |
L. reuteri NCIMB 30242 | pig | improve gastrointestinal health; inhibite sterol absorption; increase mean circulating 25-hydroxyvitamin D | |
L. reuteri ATCC 53608 | pig | recognize immunoglobulins | |
L. reuteri BSA131 | pig | resistance to pH, oxgall and antibiotics, and antimicrobial activities against enteric pathogenic, improved pig performance | [12] |
L. reuteri Pg4 | broilers | tolerate acid and bile salts; inhibit pathogenic bacteria; adhere to intestinal epithelial cells; improved broiler performance | [17] |
L. reuteri ATCC 55730 | breast milk | colonize the intestinal tract; resistance to tetracycline and lincomycin; maintain intestinal health; prevent diarrhea; modulate the immune system; used in treatment of Helicobacter pylori | |
L. reuteri DSM 17938 | ATCC 55730 | a daughter strain derived from ATCC 55730 and has the same properties as ATCC 55730 | [42] |
L. reuteri ATCC PTA 4659 | breast milk | partly prevent diet-induced obesity possibly via the mechanism of inducing liver expression of Cpt1a. | [66] |
L. reuteri ATCC PTA 6475 | breast milk | protect mice from disease manifestations of enterohemorrhagic E. coli | [67] |
L. reuteri ATCC PTA 5289 | oral cavity | improve oral malodour; reduce the number of selected periodontal pathogens in the subgingival microbiota | |
L. reuteri DPC16 | human feces | produce reuterin | [29] |
L. reuteri DSM 20016 | human feces | produce reuterin | [30] |
L. reuteri JCM 1112 | human feces | produce reuterin and cobalamin | [31] |
L. reuteri RC-14 | human vagina | produce hydrogen peroxide; adhere to uroepithelial cells and inhibit uropathogens; modulate immunity | |
L. reuteri GMN-32 | - | regulate blood glucose levels, protect cardiomyocytes and prevent diabetic cardiomyopathy in diabetes mellitus rats | [71] |
L. reuteri DSMZ 17648 | - | reduce the load of Helicobacter pylori | [72] |
L. reuteri GMNL-263 | - | ameliorate hepatic steatosis observed in high fructose treated rats; protect streptozotocin-induced diabetic rats from hyperglycemia-enhanced renal fibrosis | |
L. reuteri R2 | - | strong inhibitory activity against the dermatophyte Trichophyton tonsurans | [75] |
L. reuteri TD1 | rat | not produce reuterin, exhibit a similar onset of type 1 diabetes | [76] |
L. reuteri 100-23 | rat | stimulate the development of regulatory T cells; transiently activates intestinal epithelial cells | |
L. reuteri BR11 | guinea pig | unique antioxidant properties, show promise in the treatment of experimental colitis | [37] |
L. reuteri CRL1098 | sourdough | produce vitamin B12 | [34] |
L. reuteri LTH2584 | sourdough | produce reutericyclin | [32] |